Join Program Chair Selina R. McGee, OD, FAAO, along with Mile Brujic, OD, FAAO, and Jade Coats, OD, FAAO, for this live symposium focused on the latest evidence on nutraceuticals for ocular surface health. This event will also include an interactive, case-based clinical discussion.
The Dry Eye Diet: Evaluating the Nutraceutical Evidence
Hear the latest evidence on nutraceuticals for ocular surface health and participate in an interactive, case-based clinical discussion.

This broadcast will start in exactly:
- 0
Day(s)
- 0
Hour(s)
- 0
Minute(s)
- 0
Second(s)
Target Audience
This certified continuing medical education activity is designed for optometrists.
Grantor Statement
This activity is supported by an unrestricted educational grant from Bausch + Lomb.
Learning Objectives
Upon completion of this activity, learners should be better able to:
- Utilize diagnostic tools to accurately characterize subtypes and severity of DED
- Summarize clinical evidence regarding nutraceutical interventions for DED
- Integrate evidence-based nutraceutical approaches into personalized DED management plans
Accreditation and Credit Designation Statements
Evolve Medical Education LLC is a COPE-accredited administrator.
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
Faculty
Selina R. McGee, OD, FAAO (Chair)
BeSpoke Vision/Adjunct Professor
NSUOCO
Edmond, OKMile Brujic, OD, FAAO
Premier Vision Group
Bowling Green, OHChristen Jade Coats, OD, FAAO
Coats Eye Care
Bentonville, ARDisclosure of Relevant Financial Relationships
DISCLOSURE POLICY
In accordance with the COPE Standards for Integrity and Independence, it is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.
The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.Selina R. McGee, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Advisory Board: Ocuphire. Consultant: Aldeyra, Alcon, Allergan, Avellino, Bausch + Lomb, Bruder, Carl Zeiss Meditec, Cynosure, Dompé, EyeEco, Eyevance, Harrow, Horizon, Kala Pharmaceuticals, Lenz, Lumenis, Novartis, Optovue, Orasis, Oyster Point, RVL, ScienceBased Health, Sun Pharma, Tarsus, Théa Pharma, Topcon, Versant, Vertical, Viatris, Vital Tears, and Vyluma. Speaker’s Bureau: Alcon, Bausch + Lomb, Cynosure, Dompé, EyeEco, Eyevance, Lenz, Lumenis, Oyster Point, Optovue, Sun Pharma, Tarsus.
Mile Brujic, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of speaking, writing, participating in an advisory capacity, research or meeting support from: ABB Optical, AbbVie, Alcon, Art Optical, Apellis Pharmaceuticals, Bausch + Lomb, Contamac, CooperVision, CSEye, Dompé, Dopavision, Glaukos, Iveric Bio, Johnson & Johnson, Lenstech, MDElite, Notal Vision, Nordic Pharma, Orasis, Radius XR, RVL, Sun Pharma, Tangible Science, Tarsus, Viatris, Visionix, Walman Optical and Zea Vision.
Christen Jade Coats, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie Inc., Alcon Vision, Bausch & Lomb, Dompe Pharmaceuticals, Harrow Pharmaceuticals, Orasis Pharmaceuticals, Sun Pharmaceuticals, Tarsus Pharmaceuticals, Thea Pharmaceuticals, Trukera Medical. Speaker’s Bureau: Alcon Vision, Bausch & Lomb, Dompe Pharmaceuticals, Harrow Pharmaceuticals, Orasis Pharmaceuticals, Sun Pharmaceuticals, Tarsus Pharmaceuticals. Advisory Board: Zeiss.
The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Bausch + Lomb.This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Overview
Join Program Chair Selina R. McGee, OD, FAAO, along with Mile Brujic, OD, FAAO, and Jade Coats, OD, FAAO, for this live symposium focused on the latest evidence on nutraceuticals for ocular surface health. This event will also include an interactive, case-based clinical discussion.
Target Audience
This certified continuing medical education activity is designed for optometrists.
Grantor Statement
This activity is supported by an unrestricted educational grant from Bausch + Lomb.
Learning Objectives
Upon completion of this activity, learners should be better able to:
- Utilize diagnostic tools to accurately characterize subtypes and severity of DED
- Summarize clinical evidence regarding nutraceutical interventions for DED
- Integrate evidence-based nutraceutical approaches into personalized DED management plans
Accreditation and Credit Designation Statements
Evolve Medical Education LLC is a COPE-accredited administrator.
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
Faculty
Selina R. McGee, OD, FAAO (Chair)
BeSpoke Vision/Adjunct Professor
NSUOCO
Edmond, OKMile Brujic, OD, FAAO
Premier Vision Group
Bowling Green, OHChristen Jade Coats, OD, FAAO
Coats Eye Care
Bentonville, ARDisclosure of Relevant Financial Relationships
DISCLOSURE POLICY
In accordance with the COPE Standards for Integrity and Independence, it is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.
The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.Selina R. McGee, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Advisory Board: Ocuphire. Consultant: Aldeyra, Alcon, Allergan, Avellino, Bausch + Lomb, Bruder, Carl Zeiss Meditec, Cynosure, Dompé, EyeEco, Eyevance, Harrow, Horizon, Kala Pharmaceuticals, Lenz, Lumenis, Novartis, Optovue, Orasis, Oyster Point, RVL, ScienceBased Health, Sun Pharma, Tarsus, Théa Pharma, Topcon, Versant, Vertical, Viatris, Vital Tears, and Vyluma. Speaker’s Bureau: Alcon, Bausch + Lomb, Cynosure, Dompé, EyeEco, Eyevance, Lenz, Lumenis, Oyster Point, Optovue, Sun Pharma, Tarsus.
Mile Brujic, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of speaking, writing, participating in an advisory capacity, research or meeting support from: ABB Optical, AbbVie, Alcon, Art Optical, Apellis Pharmaceuticals, Bausch + Lomb, Contamac, CooperVision, CSEye, Dompé, Dopavision, Glaukos, Iveric Bio, Johnson & Johnson, Lenstech, MDElite, Notal Vision, Nordic Pharma, Orasis, Radius XR, RVL, Sun Pharma, Tangible Science, Tarsus, Viatris, Visionix, Walman Optical and Zea Vision.
Christen Jade Coats, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie Inc., Alcon Vision, Bausch & Lomb, Dompe Pharmaceuticals, Harrow Pharmaceuticals, Orasis Pharmaceuticals, Sun Pharmaceuticals, Tarsus Pharmaceuticals, Thea Pharmaceuticals, Trukera Medical. Speaker’s Bureau: Alcon Vision, Bausch & Lomb, Dompe Pharmaceuticals, Harrow Pharmaceuticals, Orasis Pharmaceuticals, Sun Pharmaceuticals, Tarsus Pharmaceuticals. Advisory Board: Zeiss.
The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Bausch + Lomb.This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Recommended
The Role of Presbyopia-Correcting Drops
The Role of Presbyopia-Correcting Drops
CME/CEThe Role of Presbyopia-Correcting Drops
0.25 credits0.25 creditsNew Strategies for Individualizing Treatment in DME
New Strategies for Individualizing Treatment in DME
CME/CENew Strategies for Individualizing Treatment in DME
0.25 credits0.25 creditsUnderstanding Antibody-Drug Conjugates (ADCs)
Understanding Antibody-Drug Conjugates (ADCs)
CME/CEUnderstanding Antibody-Drug Conjugates (ADCs)
0.25 credits0.25 credits